A 10-year prospective surveillance ofMycobacterium tuberculosisdrug resistance in France 1995–2004
Open Access
- 13 June 2007
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 30 (5) , 937-944
Abstract
Drug resistance surveillance and trend monitoring resistance rates bring some insights into tuberculosis (TB) control. The current study reports the characteristics of TB and drug resistance during a 10-yr prospective surveillance of culture-positive TB in France.Data for the current study was collected from 1995–2004viaa sentinel network of laboratories from university hospitals that complied with the international recommendations for the surveillance of drug resistance. Susceptibility test results were performed in each individual laboratory.Data on 13,283 patients were collected during the 10-yr period, 49% of whom had been born in France, 10% were HIV co-infected and 8% had previously been treated. As expected, previously treated and HIV co-infected patients were more likely to harbour resistant strains, especially rifampicin (RMP)-resistant strains. Among new patients, the mean resistance rate to at least one drug was 8.8%, and there was an upward trend in resistance to isoniazid and RMP (0.8–1%) related to the increase in the proportion of patients who had been born outside of France (38–53%). Among previously treated patients, the mean resistance rate to one drug was 20.6% and there was no significant time trend in resistance rates.The sentinel network provided valuable data on trends regarding the characteristics of tuberculosis and on drug resistance rates and reinforced the interest of analysing data by country of birth and history of treatment.Keywords
This publication has 9 references indexed in Scilit:
- Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysisThe Lancet, 2006
- An evaluation of data quality in a network for surveillance of Mycobacterium tuberculosis resistance to antituberculosis drugs in Ile-de-France region-2001–2002European Journal of Epidemiology, 2006
- Performance of the Genotype MTBDR Line Probe Assay for Detection of Resistance to Rifampin and Isoniazid in Strains of Mycobacterium tuberculosis with Low- and High-Level ResistanceJournal of Clinical Microbiology, 2006
- Tuberculosis Elimination in the NetherlandsEmerging Infectious Diseases, 2005
- Susceptibility testing of Mycobacterium tuberculosis to pyrazinamideJournal of Medical Microbiology, 2002
- Risk Factors for Rifampin Mono-resistant TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Results from 5 Years of Nationwide DNA Fingerprinting of Mycobacterium tuberculosis Complex Isolates in a Country with a Low Incidence of M. tuberculosis InfectionJournal of Clinical Microbiology, 1998
- Rifampin‐Monoresistant Tuberculosis in New York City, 1993–1994Clinical Infectious Diseases, 1997
- Trends in the prevalence of primary drug resistance in pulmonary tuberculosis in france from 1962 to 1970: A national surveyTubercle, 1972